▶ 調査レポート

世界のナノバイオテクノロジー市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Nanobiotechnology Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のナノバイオテクノロジー市場規模・現状・予測(2021年-2027年) / Global Nanobiotechnology Market Size, Status and Forecast 2021-2027 / QYR2104Z4003資料のイメージです。• レポートコード:QYR2104Z4003
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥565,500 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥848,250 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,131,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、ナノバイオテクノロジーのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(0-10 ナノメートル、10-100 ナノメートル)、用途別市場規模(医薬品、医療機器、医学研究、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・ナノバイオテクノロジーの市場動向
・企業の競争状況、市場シェア
・ナノバイオテクノロジーの種類別市場規模(0-10 ナノメートル、10-100 ナノメートル)
・ナノバイオテクノロジーの用途別市場規模(医薬品、医療機器、医学研究、その他)
・ナノバイオテクノロジーの北米市場規模2016-2027(アメリカ、カナダ)
・ナノバイオテクノロジーのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・ナノバイオテクノロジーのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ナノバイオテクノロジーの中南米市場規模2016-2027(メキシコ、ブラジル)
・ナノバイオテクノロジーの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Aduro BioTech、Calando Pharmaceuticals、Biosante Phosphate Pharmaceuticals、Celgene Corporation、Elan Pharmaceuticals、Flamel Technologies、Nanophase Technologies、Sigma Aldrich Company、Dendritic Nanotechnologies、SkyePharma Pharmaceuticals)
・結論

Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule. The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics.

Market Analysis and Insights: Global Nanobiotechnology Market
The global Nanobiotechnology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanobiotechnology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanobiotechnology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanobiotechnology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanobiotechnology market.

Global Nanobiotechnology Scope and Market Size
Nanobiotechnology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanobiotechnology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
0-10 nm
10-100 nm

Segment by Application
Pharmaceuticals
Medical Devices
Medical Research
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 0-10 nm
1.2.3 10-100 nm
1.3 Market by Application
1.3.1 Global Nanobiotechnology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceuticals
1.3.3 Medical Devices
1.3.4 Medical Research
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nanobiotechnology Market Perspective (2016-2027)
2.2 Nanobiotechnology Growth Trends by Regions
2.2.1 Nanobiotechnology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanobiotechnology Historic Market Share by Regions (2016-2021)
2.2.3 Nanobiotechnology Forecasted Market Size by Regions (2022-2027)
2.3 Nanobiotechnology Industry Dynamic
2.3.1 Nanobiotechnology Market Trends
2.3.2 Nanobiotechnology Market Drivers
2.3.3 Nanobiotechnology Market Challenges
2.3.4 Nanobiotechnology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nanobiotechnology Players by Revenue
3.1.1 Global Top Nanobiotechnology Players by Revenue (2016-2021)
3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2016-2021)
3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanobiotechnology Revenue
3.4 Global Nanobiotechnology Market Concentration Ratio
3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2020
3.5 Nanobiotechnology Key Players Head office and Area Served
3.6 Key Players Nanobiotechnology Product Solution and Service
3.7 Date of Enter into Nanobiotechnology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nanobiotechnology Breakdown Data by Type
4.1 Global Nanobiotechnology Historic Market Size by Type (2016-2021)
4.2 Global Nanobiotechnology Forecasted Market Size by Type (2022-2027)

5 Nanobiotechnology Breakdown Data by Application
5.1 Global Nanobiotechnology Historic Market Size by Application (2016-2021)
5.2 Global Nanobiotechnology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nanobiotechnology Market Size (2016-2027)
6.2 North America Nanobiotechnology Market Size by Type
6.2.1 North America Nanobiotechnology Market Size by Type (2016-2021)
6.2.2 North America Nanobiotechnology Market Size by Type (2022-2027)
6.2.3 North America Nanobiotechnology Market Size by Type (2016-2027)
6.3 North America Nanobiotechnology Market Size by Application
6.3.1 North America Nanobiotechnology Market Size by Application (2016-2021)
6.3.2 North America Nanobiotechnology Market Size by Application (2022-2027)
6.3.3 North America Nanobiotechnology Market Size by Application (2016-2027)
6.4 North America Nanobiotechnology Market Size by Country
6.4.1 North America Nanobiotechnology Market Size by Country (2016-2021)
6.4.2 North America Nanobiotechnology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Nanobiotechnology Market Size (2016-2027)
7.2 Europe Nanobiotechnology Market Size by Type
7.2.1 Europe Nanobiotechnology Market Size by Type (2016-2021)
7.2.2 Europe Nanobiotechnology Market Size by Type (2022-2027)
7.2.3 Europe Nanobiotechnology Market Size by Type (2016-2027)
7.3 Europe Nanobiotechnology Market Size by Application
7.3.1 Europe Nanobiotechnology Market Size by Application (2016-2021)
7.3.2 Europe Nanobiotechnology Market Size by Application (2022-2027)
7.3.3 Europe Nanobiotechnology Market Size by Application (2016-2027)
7.4 Europe Nanobiotechnology Market Size by Country
7.4.1 Europe Nanobiotechnology Market Size by Country (2016-2021)
7.4.2 Europe Nanobiotechnology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nanobiotechnology Market Size (2016-2027)
8.2 Asia-Pacific Nanobiotechnology Market Size by Type
8.2.1 Asia-Pacific Nanobiotechnology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanobiotechnology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanobiotechnology Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanobiotechnology Market Size by Application
8.3.1 Asia-Pacific Nanobiotechnology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanobiotechnology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanobiotechnology Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanobiotechnology Market Size by Region
8.4.1 Asia-Pacific Nanobiotechnology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanobiotechnology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nanobiotechnology Market Size (2016-2027)
9.2 Latin America Nanobiotechnology Market Size by Type
9.2.1 Latin America Nanobiotechnology Market Size by Type (2016-2021)
9.2.2 Latin America Nanobiotechnology Market Size by Type (2022-2027)
9.2.3 Latin America Nanobiotechnology Market Size by Type (2016-2027)
9.3 Latin America Nanobiotechnology Market Size by Application
9.3.1 Latin America Nanobiotechnology Market Size by Application (2016-2021)
9.3.2 Latin America Nanobiotechnology Market Size by Application (2022-2027)
9.3.3 Latin America Nanobiotechnology Market Size by Application (2016-2027)
9.4 Latin America Nanobiotechnology Market Size by Country
9.4.1 Latin America Nanobiotechnology Market Size by Country (2016-2021)
9.4.2 Latin America Nanobiotechnology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nanobiotechnology Market Size (2016-2027)
10.2 Middle East & Africa Nanobiotechnology Market Size by Type
10.2.1 Middle East & Africa Nanobiotechnology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanobiotechnology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanobiotechnology Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanobiotechnology Market Size by Application
10.3.1 Middle East & Africa Nanobiotechnology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanobiotechnology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanobiotechnology Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanobiotechnology Market Size by Country
10.4.1 Middle East & Africa Nanobiotechnology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanobiotechnology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Aduro BioTech
11.1.1 Aduro BioTech Company Details
11.1.2 Aduro BioTech Business Overview
11.1.3 Aduro BioTech Nanobiotechnology Introduction
11.1.4 Aduro BioTech Revenue in Nanobiotechnology Business (2016-2021)
11.1.5 Aduro BioTech Recent Development
11.2 Calando Pharmaceuticals
11.2.1 Calando Pharmaceuticals Company Details
11.2.2 Calando Pharmaceuticals Business Overview
11.2.3 Calando Pharmaceuticals Nanobiotechnology Introduction
11.2.4 Calando Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021)
11.2.5 Calando Pharmaceuticals Recent Development
11.3 Biosante Phosphate Pharmaceuticals
11.3.1 Biosante Phosphate Pharmaceuticals Company Details
11.3.2 Biosante Phosphate Pharmaceuticals Business Overview
11.3.3 Biosante Phosphate Pharmaceuticals Nanobiotechnology Introduction
11.3.4 Biosante Phosphate Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021)
11.3.5 Biosante Phosphate Pharmaceuticals Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Details
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Nanobiotechnology Introduction
11.4.4 Celgene Corporation Revenue in Nanobiotechnology Business (2016-2021)
11.4.5 Celgene Corporation Recent Development
11.5 Elan Pharmaceuticals
11.5.1 Elan Pharmaceuticals Company Details
11.5.2 Elan Pharmaceuticals Business Overview
11.5.3 Elan Pharmaceuticals Nanobiotechnology Introduction
11.5.4 Elan Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021)
11.5.5 Elan Pharmaceuticals Recent Development
11.6 Flamel Technologies
11.6.1 Flamel Technologies Company Details
11.6.2 Flamel Technologies Business Overview
11.6.3 Flamel Technologies Nanobiotechnology Introduction
11.6.4 Flamel Technologies Revenue in Nanobiotechnology Business (2016-2021)
11.6.5 Flamel Technologies Recent Development
11.7 Nanophase Technologies
11.7.1 Nanophase Technologies Company Details
11.7.2 Nanophase Technologies Business Overview
11.7.3 Nanophase Technologies Nanobiotechnology Introduction
11.7.4 Nanophase Technologies Revenue in Nanobiotechnology Business (2016-2021)
11.7.5 Nanophase Technologies Recent Development
11.8 Sigma Aldrich Company
11.8.1 Sigma Aldrich Company Company Details
11.8.2 Sigma Aldrich Company Business Overview
11.8.3 Sigma Aldrich Company Nanobiotechnology Introduction
11.8.4 Sigma Aldrich Company Revenue in Nanobiotechnology Business (2016-2021)
11.8.5 Sigma Aldrich Company Recent Development
11.9 Dendritic Nanotechnologies
11.9.1 Dendritic Nanotechnologies Company Details
11.9.2 Dendritic Nanotechnologies Business Overview
11.9.3 Dendritic Nanotechnologies Nanobiotechnology Introduction
11.9.4 Dendritic Nanotechnologies Revenue in Nanobiotechnology Business (2016-2021)
11.9.5 Dendritic Nanotechnologies Recent Development
11.10 SkyePharma Pharmaceuticals
11.10.1 SkyePharma Pharmaceuticals Company Details
11.10.2 SkyePharma Pharmaceuticals Business Overview
11.10.3 SkyePharma Pharmaceuticals Nanobiotechnology Introduction
11.10.4 SkyePharma Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021)
11.10.5 SkyePharma Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nanobiotechnology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 0-10 nm
Table 3. Key Players of 10-100 nm
Table 4. Global Nanobiotechnology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Nanobiotechnology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nanobiotechnology Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Nanobiotechnology Market Share by Regions (2016-2021)
Table 8. Global Nanobiotechnology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Nanobiotechnology Market Share by Regions (2022-2027)
Table 10. Nanobiotechnology Market Trends
Table 11. Nanobiotechnology Market Drivers
Table 12. Nanobiotechnology Market Challenges
Table 13. Nanobiotechnology Market Restraints
Table 14. Global Nanobiotechnology Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Nanobiotechnology Market Share by Players (2016-2021)
Table 16. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanobiotechnology as of 2020)
Table 17. Ranking of Global Top Nanobiotechnology Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Nanobiotechnology Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nanobiotechnology Product Solution and Service
Table 21. Date of Enter into Nanobiotechnology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nanobiotechnology Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Nanobiotechnology Revenue Market Share by Type (2016-2021)
Table 25. Global Nanobiotechnology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Nanobiotechnology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Nanobiotechnology Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Nanobiotechnology Revenue Market Share by Application (2016-2021)
Table 29. Global Nanobiotechnology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Nanobiotechnology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Nanobiotechnology Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Nanobiotechnology Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Nanobiotechnology Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Nanobiotechnology Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Nanobiotechnology Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Nanobiotechnology Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Nanobiotechnology Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Nanobiotechnology Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Nanobiotechnology Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Nanobiotechnology Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nanobiotechnology Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Nanobiotechnology Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Nanobiotechnology Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Nanobiotechnology Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Nanobiotechnology Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Nanobiotechnology Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Nanobiotechnology Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Nanobiotechnology Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nanobiotechnology Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Nanobiotechnology Market Size by Country (2022-2027) & (US$ Million)
Table 61. Aduro BioTech Company Details
Table 62. Aduro BioTech Business Overview
Table 63. Aduro BioTech Nanobiotechnology Product
Table 64. Aduro BioTech Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 65. Aduro BioTech Recent Development
Table 66. Calando Pharmaceuticals Company Details
Table 67. Calando Pharmaceuticals Business Overview
Table 68. Calando Pharmaceuticals Nanobiotechnology Product
Table 69. Calando Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 70. Calando Pharmaceuticals Recent Development
Table 71. Biosante Phosphate Pharmaceuticals Company Details
Table 72. Biosante Phosphate Pharmaceuticals Business Overview
Table 73. Biosante Phosphate Pharmaceuticals Nanobiotechnology Product
Table 74. Biosante Phosphate Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 75. Biosante Phosphate Pharmaceuticals Recent Development
Table 76. Celgene Corporation Company Details
Table 77. Celgene Corporation Business Overview
Table 78. Celgene Corporation Nanobiotechnology Product
Table 79. Celgene Corporation Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 80. Celgene Corporation Recent Development
Table 81. Elan Pharmaceuticals Company Details
Table 82. Elan Pharmaceuticals Business Overview
Table 83. Elan Pharmaceuticals Nanobiotechnology Product
Table 84. Elan Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 85. Elan Pharmaceuticals Recent Development
Table 86. Flamel Technologies Company Details
Table 87. Flamel Technologies Business Overview
Table 88. Flamel Technologies Nanobiotechnology Product
Table 89. Flamel Technologies Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 90. Flamel Technologies Recent Development
Table 91. Nanophase Technologies Company Details
Table 92. Nanophase Technologies Business Overview
Table 93. Nanophase Technologies Nanobiotechnology Product
Table 94. Nanophase Technologies Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 95. Nanophase Technologies Recent Development
Table 96. Sigma Aldrich Company Company Details
Table 97. Sigma Aldrich Company Business Overview
Table 98. Sigma Aldrich Company Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 99. Sigma Aldrich Company Recent Development
Table 100. Dendritic Nanotechnologies Company Details
Table 101. Dendritic Nanotechnologies Business Overview
Table 102. Dendritic Nanotechnologies Nanobiotechnology Product
Table 103. Dendritic Nanotechnologies Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 104. Dendritic Nanotechnologies Recent Development
Table 105. SkyePharma Pharmaceuticals Company Details
Table 106. SkyePharma Pharmaceuticals Business Overview
Table 107. SkyePharma Pharmaceuticals Nanobiotechnology Product
Table 108. SkyePharma Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million)
Table 109. SkyePharma Pharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanobiotechnology Market Share by Type: 2020 VS 2027
Figure 2. 0-10 nm Features
Figure 3. 10-100 nm Features
Figure 4. Global Nanobiotechnology Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceuticals Case Studies
Figure 6. Medical Devices Case Studies
Figure 7. Medical Research Case Studies
Figure 8. Other Case Studies
Figure 9. Nanobiotechnology Report Years Considered
Figure 10. Global Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Nanobiotechnology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nanobiotechnology Market Share by Regions: 2020 VS 2027
Figure 13. Global Nanobiotechnology Market Share by Regions (2022-2027)
Figure 14. Global Nanobiotechnology Market Share by Players in 2020
Figure 15. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanobiotechnology as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Nanobiotechnology Revenue in 2020
Figure 17. Global Nanobiotechnology Revenue Market Share by Type (2016-2021)
Figure 18. Global Nanobiotechnology Revenue Market Share by Type (2022-2027)
Figure 19. North America Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Nanobiotechnology Market Share by Type (2016-2027)
Figure 21. North America Nanobiotechnology Market Share by Application (2016-2027)
Figure 22. North America Nanobiotechnology Market Share by Country (2016-2027)
Figure 23. United States Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Nanobiotechnology Market Share by Type (2016-2027)
Figure 27. Europe Nanobiotechnology Market Share by Application (2016-2027)
Figure 28. Europe Nanobiotechnology Market Share by Country (2016-2027)
Figure 29. Germany Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Nanobiotechnology Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Nanobiotechnology Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Nanobiotechnology Market Share by Region (2016-2027)
Figure 39. China Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Nanobiotechnology Market Share by Type (2016-2027)
Figure 47. Latin America Nanobiotechnology Market Share by Application (2016-2027)
Figure 48. Latin America Nanobiotechnology Market Share by Country (2016-2027)
Figure 49. Mexico Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Nanobiotechnology Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Nanobiotechnology Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Nanobiotechnology Market Share by Country (2016-2027)
Figure 55. Turkey Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Aduro BioTech Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 59. Calando Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 60. Biosante Phosphate Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 61. Celgene Corporation Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 62. Elan Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 63. Flamel Technologies Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 64. Nanophase Technologies Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 65. Sigma Aldrich Company Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 66. Dendritic Nanotechnologies Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 67. SkyePharma Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed